REPORT ID 5106

United States Androgens Market Report 2017

Publish Date
20-Dec-17
Pages
100
Format
Electronic (PDF)

In this report, the United States Androgens market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Androgens in these regions, from 2012 to 2022 (forecast).

United States Androgens market competition by top manufacturers/players, with Androgens sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Pfizer
    Sanofi-Aventis
    Abbott
    Dendreon
    AstraZeneca
    Anabolics
    ABBVIE
    Wuhan Nuohui Pharmaceutical And Chwmical

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Solution
    Implant
    Capsule
    Kit
    Tablet
    Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Anemias
    Delayed Growth Spurt
    Lichen Sclerosus
    Microphallus
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Androgens Market Report 2017
1 Androgens Overview
    1.1 Product Overview and Scope of Androgens
    1.2 Classification of Androgens by Product Category
        1.2.1 United States Androgens Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Androgens Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Solution
        1.2.4 Implant
        1.2.5 Capsule
        1.2.6 Kit
        1.2.7 Tablet
        1.2.8 Other
    1.3 United States Androgens Market by Application/End Users
        1.3.1 United States Androgens Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Anemias
        1.3.3 Delayed Growth Spurt
        1.3.4 Lichen Sclerosus
        1.3.5 Microphallus
        1.3.6 Other
    1.4 United States Androgens Market by Region
        1.4.1 United States Androgens Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Androgens Status and Prospect (2012-2022)
        1.4.3 Southwest Androgens Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Androgens Status and Prospect (2012-2022)
        1.4.5 New England Androgens Status and Prospect (2012-2022)
        1.4.6 The South Androgens Status and Prospect (2012-2022)
        1.4.7 The Midwest Androgens Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Androgens (2012-2022)
        1.5.1 United States Androgens Sales and Growth Rate (2012-2022)
        1.5.2 United States Androgens Revenue and Growth Rate (2012-2022)

2 United States Androgens Market Competition by Players/Suppliers
    2.1 United States Androgens Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Androgens Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Androgens Average Price by Players/Suppliers (2012-2017)
    2.4 United States Androgens Market Competitive Situation and Trends
        2.4.1 United States Androgens Market Concentration Rate
        2.4.2 United States Androgens Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Androgens Manufacturing Base Distribution, Sales Area, Product Type

3 United States Androgens Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Androgens Sales and Market Share by Region (2012-2017)
    3.2 United States Androgens Revenue and Market Share by Region (2012-2017)
    3.3 United States Androgens Price by Region (2012-2017)

4 United States Androgens Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Androgens Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Androgens Revenue and Market Share by Type (2012-2017)
    4.3 United States Androgens Price by Type (2012-2017)
    4.4 United States Androgens Sales Growth Rate by Type (2012-2017)

5 United States Androgens Sales (Volume) by Application (2012-2017)
    5.1 United States Androgens Sales and Market Share by Application (2012-2017)
    5.2 United States Androgens Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Androgens Players/Suppliers Profiles and Sales Data
    6.1 Pfizer
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Androgens Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Pfizer Androgens Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Sanofi-Aventis
        6.2.2 Androgens Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Sanofi-Aventis Androgens Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Abbott
        6.3.2 Androgens Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Abbott Androgens Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Dendreon
        6.4.2 Androgens Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Dendreon Androgens Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 AstraZeneca
        6.5.2 Androgens Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 AstraZeneca Androgens Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Anabolics
        6.6.2 Androgens Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Anabolics Androgens Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 ABBVIE
        6.7.2 Androgens Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 ABBVIE Androgens Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Wuhan Nuohui Pharmaceutical And Chwmical
        6.8.2 Androgens Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Wuhan Nuohui Pharmaceutical And Chwmical Androgens Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview

7 Androgens Manufacturing Cost Analysis
    7.1 Androgens Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Androgens

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Androgens Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Androgens Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Androgens Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Androgens Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Androgens Sales Volume Forecast by Type (2017-2022)
    11.3 United States Androgens Sales Volume Forecast by Application (2017-2022)
    11.4 United States Androgens Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer